Flores-Umanzor, E, Cruz-González, I, Cepas-Guillén, P, Millán, X, Antúnez-Muiños, P, Asmarats, L, Laffond, A, Regueiro, A, López-Tejero, S, Li, CHP, Sanchis, L, Rodés-Cabau, J, Arzamendi, D, Freixa, X. Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(6)DOI:10.1016/j.rec.2025.12.008. PMID:41412468. IF:4.900(Q1/2D).

Trimaille, A, Morel, O, Alperi, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Muñoz-García, A, Nuche, J, Franzone, A, Urena, M, Asmarats, L, Regueiro, A, del Trigo, M, Auffret, V, del Val, D, Serra, V, Carmona, A, Avanzas, P, Fradejas-Sastre, V, Sanchez, I, Trichilo, M, Maneiro, N, Molaro, MI, Fischer, Q, Arzamendi, D, Flores-Umanzor, E, Oteo, JF, Nolf, M, Alfonso, F, Pockels, PD, Elkadiri, C, Cepas-Guillén, P, Avvedimento, M, Rodés-Cabau, J. Prognostic value of early haemodynamic valve deterioration after TAVI. EuroIntervention. 2026; 22(11)DOI:10.4244/EIJ-D-25-01370. PMID:42186872. IF:9.500(Q1/1D).

Cenko, E, Manfrini, O, Yoon, J, Bergami, M, Vasiljevic, Z, Mendieta, G, Zdravkovic, M, Vavlukis, M, Kedev, S, Milicic, D, Ottani, F, Badimon, L, Bugiardini, R. The paradox of SMURF-less outcomes and its implication for diabetes. European Heart Journal-Quality of Care and Clinical Outcomes. 2026; 12(4)DOI:10.1093/ehjqcco/qcag012. PMID:41606783. IF:4.600(Q1/2D).

Bernardo, A, Mato, G, Calandrelli, M, Medus, J, Curiale, A. Parameter-efficient adaptation of foundational models for automated myocardial strain analysis. Biomedical Physics & Engineering Express. 2026; 12(3)DOI:10.1088/2057-1976/ae7c09. PMID:42276109. IF:(Q/D).

Chico, A, Aguilera-Hurtado, E, Albareda, M, Moreno-Fernández, J, Beato-Vibora, P, Fernández-Rubio, E, Cuesta, M, Bartual, A, Ampudia-Blasco, FJ, Bandrés, O, Ares, J, Rivero, MT, Picón-César, MJ. A multicenter prospective evaluation of the benefits of Dexcom ONE plus in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study. ACTA DIABETOLOGICA. 2026; 63(6)DOI:10.1007/s00592-026-02682-9. PMID:41964691. IF:2.900(Q3/6D).

Lazarus, JV, White, TM, Agirre-Garrido, L, Abeysekera, KWM, Brennan, PN, Bruha, R, Buttigieg, S, Carrieri, P, Cortez-Pinto, H, Flisiak, R, Francque, SMA, Frühbeck, G, Gheorghe, LS, Hagström, H, Holleboom, AG, Ivanov, K, Jensterle, M, Jepsen, P, Kupcinskas, J, Mark, HE, Mauricio, D, Bibi, SM, Moreno, C, Mrzljak, A, Papanicolaou, E, Papp, M, Papatheodoridis, G, Peck-Radosavljevic, M, Pugliese, N, Ryan, JD, Ribeiro, RT, Salupere, R, Skladany, L, Tolmane, I, Yki-Järvinen, H, Schattenberg, JM, Pericàs, JM. Assessing Europe's policy readiness to confront the MASLD/MASH public health threat. Lancet Regional Health-Europe. 2026; 65DOI:10.1016/j.lanepe.2026.101713. PMID:42266904. IF:13.000(Q1/1D).

Martinez-Mores, S, Fillat, MBV, Vlacho, B, Navas, E, Fernandez-Camins, B, Franch-Nadal, J, Mauricio, D. Prevalence and clinical characteristics of erectile dysfunction among men with type 2 diabetes in primary care: A cross-sectional study in Catalonia. Primary Care Diabetes. 2026; 20(3)DOI:10.1016/j.pcd.2026.04.006. PMID:42000296. IF:2.300(Q2/5D).

Ramon-Granés, M, Fernàndez-Camins, B, Lapena-Estella, C, Orfila-Pernas, F, de la Puente, JB, Vlacho, B, Mauricio, D, Navas-Méndez, E, Franch-Nadal, J. Clinical trends in Catalonia's Primary Care Setting (2018-2023) in Elderly (=75 years) and Frail Adults with Type 2 Diabetes. Primary Care Diabetes. 2026; 20(3)DOI:10.1016/j.pcd.2026.03.010. PMID:41916804. IF:2.300(Q2/5D).